Products Categories
CAS No.: | 470-37-1 |
---|---|
Name: | Cinobufagin |
Article Data: | 3 |
Molecular Structure: | |
Formula: | C26H34O6 |
Molecular Weight: | 442.552 |
Synonyms: | 5b-Bufa-20,22-dienolide, 14,15b-epoxy-3b,16b-dihydroxy-, 16-acetate (7CI,8CI);Cinobufagine;Cinobufagin (6CI);NSC 90325; |
EINECS: | 205-398-1 |
Density: | 1.29 g/cm3 |
Melting Point: | 133 °C(lit.) |
Boiling Point: | 595.4 °C at 760 mmHg |
Flash Point: | 199.4 °C |
Hazard Symbols: | Xi, T+, Xn |
Risk Codes: | 36/37/38-26/27/28-42/43-20/22 |
Safety: | 26-36-45-36/37/39-22 |
Transport Information: | UN 2811 6.1/PG 1 |
PSA: | 89.27000 |
LogP: | 3.79990 |
This chemical is called Cinobufagin, and its CAS registry number is 470-37-1. With the molecular formula of C26H34O6, its product category is Steroids. It has similar effects to digitalis and is used in traditional Chinese medicine. In addition, it's used as extinguishing agent.
Other characteristics of the Cinobufagin can be summarised as followings: (1)ACD/LogP: 1.85; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 2; (4)ACD/LogD (pH 7.4): 2; (5)ACD/BCF (pH 5.5): 42; (6)ACD/BCF (pH 7.4): 42; (7)ACD/KOC (pH 5.5): 503; (8)#Freely Rotating Bonds: 4; (9)Polar Surface Area: 85.36 Å2; (10)Index of Refraction: 1.595; (11)Molar Refractivity: 116.638 cm3; (12)Molar Volume: 343.102 cm3; (13)Polarizability: 46.239×10-24cm3; (14)Surface Tension: 53.781 dyne/cm; (15)Density: 1.29 g/cm3; (16)Flash Point: 199.434 °C; (17)Enthalpy of Vaporization: 101.821 kJ/mol; (18)Boiling Point: 595.417 °C at 760 mmHg; (19)Vapour Pressure: 0 mmHg at 25°C.
When you are using this chemical, please be cautious about it as the following: This chemical is irritating / harmful to eyes, respiratory system and skin. You should wear suitable protective clothing if you use it. In case of contacting with eyes, rinse immediately with plenty of water and seek medical advice.
You can still convert the following datas into molecular structure:
1.SMILES: O=C\1O\C=C(/C=C/1)[C@@H]4[C@@]6(C)CC[C@H]3[C@@H](CC[C@@H]2C[C@@H](O)CC[C@@]23C)[C@]65O[C@@H]5[C@@H]4OC(=O)C
2.InChI: InChI=1/C26H34O6/c1-14(27)31-22-21(15-4-7-20(29)30-13-15)25(3)11-9-18-19(26(25)23(22)32-26)6-5-16-12-17(28)8-10-24(16,18)2/h4,7,13,16-19,21-23,28H,5-6,8-12H2,1-3H3/t16-,17+,18+,19-,21+,22-,23-,24+,25-,26-/m1/s1
3.InChIKey: SCULJPGYOQQXTK-OLRINKBEBZ
The toxicity data is as follows:
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source cat LDLo intravenous 230ug/kg (0.23mg/kg) Journal of Pharmacology and Experimental Therapeutics. Vol. 49, Pg. 561, 1933. cat LDLo unreported 209ug/kg (0.209mg/kg) Pharmaceutica Acta Helvetiae. Vol. 24, Pg. 222, 1949. mouse LD50 intravenous 1210ug/kg (1.21mg/kg) BEHAVIORAL: TREMOR
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: ANTIPSYCHOTICChemical and Pharmaceutical Bulletin. Vol. 24, Pg. 1714, 1976. mouse LD50 oral 144mg/kg (144mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: ATAXIANippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 86, Pg. 269, 1985.